Comparative In Vitro and In Silico Analyses of Variants in Splicing Regions of BRCA1 and BRCA2 Genes and Characterization of Novel Pathogenic Mutations-Reference-Cited by-同舟云学术

Comparative In Vitro and In Silico Analyses of Variants in Splicing Regions of BRCA1 and BRCA2 Genes and Characterization of Novel Pathogenic Mutations

Published:2013-02-22 Issue:2 Volume:8 Page:e57173
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Colombo Mara,De Vecchi Giovanna,Caleca Laura,Foglia Claudia,Ripamonti Carla B.,Ficarazzi Filomena,Barile Monica,Varesco Liliana,Peissel Bernard,Manoukian Siranoush,Radice Paolo

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference59 articles.

1. The emerging landscape of breast cancer susceptibility;MR Stratton;Nat Genet,2008

2. Genetic susceptibility to breast cancer;N Mavaddat;Mol Oncol,2010

3. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies;A Antoniou;Am J Hum Genet,2003

4. The nonsense-mediated mRNA decay pathway triggers degradation of most BRCA1 mRNAs bearing premature termination codons;L Perrin-Vidoz;Hum Mol Genet,2002

5. Clinical relevance of rare germline sequence variants in cancer genes: evolution and application of classification models;AB Spurdle;Curr Opin Genet Dev,2010

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Determination of genetic predisposition to early breast cancer in women of Kazakh ethnicity;Oncotarget;2023-10-04

2. Unexpected finding of a rare pathogenic germline BRCA1 variant in an intrahepatic cholangiocarcinoma using the Oncomine Focus DNA assay: clinical and diagnostic implications;Molecular Biology Reports;2023-06-20

3. Unexpected finding of a rare pathogenic germline BRCA1 variant in an intrahepatic cholangiocarcinoma using the Oncomine Focus DNA assay: clinical and diagnostic implications;2023-05-08

4. APPLICATION OF THE ACMG/AMP FRAMEWORK TO CAPTURE EVIDENCE RELEVANT TO PREDICTED AND OBSERVED IMPACT ON SPLICING: RECOMMENDATIONS FROM THE CLINGEN SVI SPLICING SUBGROUP;2023-02-26

5. BRCA1 and BRCA2 mutations and their clinical relevance in selected women diagnosed with triple-negative breast cancer in Kenya: a descriptive cross-sectional study;Pan African Medical Journal;2023